Note 8 - Segment Information and Disaggregated Revenue

6 Months Ended

Dec. 31, 2019

Segment Reporting Disclosure [Text Block]

Note

Segment Information

and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe, for the

three

months ended

December 31, 2019

and

2018

were

$2,319

and

$1,274,

respectively and for the

six

months ended

December 31, 2019

and

2018

were

$4,345

and

$2,513,

respectively.

Financial information relating to the

three

months ended

December 31, 2019

and

2018

operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (loss)			Depreciation		Expenditures
Contract Manufacturing	2019	$	11,501	$	2,303	$	13,804	$	1,927		$	69	$	43
	2018		10,498		1,258		11,756		1,246			66		269

Branded Proprietary Products	2019		2		-		2		(27	)		-		-
	2018		48		12		60		21			-		-

Other Nutraceutical Businesses	2019		375		16		391		126			-		-
	2018		181		4		185		63			-		-

Total Company	2019		11,878		2,319		14,197		2,026			69		43
	2018		10,727		1,274		12,001		1,330			66		269

Financial information relating to the

six

months ended

December 31, 2019

and

2018

operations by business segment and disaggregated revenues was as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures
Contract Manufacturing	2019	$	20,502	$	4,286	$	24,788	$	3,177		$	159	$	101
	2018		19,153		2,455		21,608		2,328			131		287

Branded Proprietary Products	2019		4		10		14		(30	)		-		-
	2018		119		19		138		42			-		-

Other Nutraceutical Businesses	2019		752		49		801		278			1		-
	2018		520		39		559		179			1		-

Total Company	2019		21,258		4,345		25,603		3,425			160		101
	2018		19,792		2,513		22,305		2,549			132		287

	Total Assets as of
	December 31,		June 30,
	2019		2019
Contract Manufacturing	$	18,017	$	17,580

Branded Proprietary Products
		395		427
Other Nutraceutical Businesses
		1,559		1,783
Total Company	$	19,971	$	19,790